Transcription profile of genes affected in response to pathological changes in drug-induced rat model of acute kidney injury

References

• Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756–766
   PubMed Web of Science ®Google Scholar
• Ferguson MA, Waikar SS. Established and emerging markers of kidney function. Clin Chem. 2012;58:680–689
   PubMed Web of Science ®Google Scholar
• Liu KD, Brakeman PR. Renal repair and recovery. Crit Care Med. 2008;36:S187–S192
   PubMed Web of Science ®Google Scholar
• Perazella MA. Drug-induced nephropathy: An update. Expert Opin Drug Saf. 2005;4:689–706
   PubMed Web of Science ®Google Scholar
• Markowitz GS, Perazella MA. Drug-induced renal failure: A focus on tubulointerstitial disease. Clin Chem Acta. 2005;351:31–47
   PubMed Web of Science ®Google Scholar
• Zager RA. Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin Nephrol. 1997;17:3–14
   PubMed Web of Science ®Google Scholar
• Supavekin S, Weijia Z, Raju K, et al. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003;63:1714–1724
   PubMed Web of Science ®Google Scholar
• de Broe ME, Porter GA, eds. Clinical nephrotoxins. In: Renal Injury from Drugs and Chemicals. The Netherlands: Springer/Kluwer Acad Pub; 2009:29–42
   Google Scholar
• Vanmassenhove J, Raymond V, Evi N, et al. Urinary and serum biomarkers for the diagnosis of acute kidney injury: An in-depth review of the literature. Nephrol Dial Transplant. 2013;28:254–273
   PubMed Web of Science ®Google Scholar
• Sahu BD, Reddy KKR, Putcha UK, et al. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Food Chem Toxicol. 2011;49:3090–3097
   PubMed Web of Science ®Google Scholar
• Vishal S, Vaidya M, Ferguson A, et al. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008;48:463–493
   PubMed Web of Science ®Google Scholar
• Won KH, Veronique B, Rekha A, et al. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 2004;62:237–244
   Web of Science ®Google Scholar
• Takaharu I, Joseph VB, Véronique B, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273:4135–4142
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Amish AS, Raghu K. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem. 2005;280:8094–8100
   PubMed Web of Science ®Google Scholar
• Wetzel P, Haag J, Campean V, et al. Bone morphogenetic protein-7 expression and activity in the human adult normal kidney is predominantly localized to the distal nephron. Kidney Int. 2006;70:717–723
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Kalluri R. Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatr Nephrol. 2008;23:1395–1398
   PubMed Web of Science ®Google Scholar
• Tanaka M, Endo S, Okuda T, et al. Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury. Kidney Int. 2008;73:181–191
   PubMed Web of Science ®Google Scholar
• Xue Q, Yu L, Xiao LW, et al. Osteopontin expression in progressive renal injury in remnant kidney: Role of angiotensin II. Kidney Int. 2000;58:1469–1480
   PubMed Web of Science ®Google Scholar
• Florian TG, Jorge I, Zhuma H, et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int. 2005;67:1772–1784
   PubMed Web of Science ®Google Scholar
• Stokman G, Ingrid S, Nike C, et al. SDF-1 provides morphological and functional protection against renal ischemia/reperfusion injury. Nephrol Dial Transplant. 2010;25:3852–3859
   PubMed Web of Science ®Google Scholar
• Kameswaran S, Sean PM, Theodore CS. A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol. 2002;282:F431–F441
   PubMed Web of Science ®Google Scholar
• Edward J, Sharples N, Patel PB, et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol. 2004;15:2115–2124
   PubMed Web of Science ®Google Scholar
• deVries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med. 1995;27:537–541
   PubMed Web of Science ®Google Scholar
• Eppinger MJ, Ward PA, Bolling SF. Regulatory effects of interleukin-10 on lung ischemia–reperfusion injury. J Thorac Cardiovasc Surg. 1996;112:1301–1305
   PubMed Web of Science ®Google Scholar
• Jiangping D, Yukimasa K, His C, et al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 2001;60:2118–2128
   PubMed Web of Science ®Google Scholar
• Tian W, Zhang Z, Cohen DM. MAPK signaling and the kidney. Am J Physiol Renal Physiol. 2000;279:F593–F604
   PubMed Web of Science ®Google Scholar
• Masaki T, Rita F, Prudence A, et al. Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int. 2003;63:1256–1264
   PubMed Web of Science ®Google Scholar
• Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625–637
   PubMed Web of Science ®Google Scholar
• McNiece IK, Briddell RA. Stem cell factor. J Leukoc Biol. 1995;58:14–22
   PubMed Web of Science ®Google Scholar
• Bengatta S, Arnould C, Letavernier E, et al. MMP9 and SCF protect from apoptosis in acute kidney injury. J Am Soc Nephrol. 2009;20:787–797
   PubMed Web of Science ®Google Scholar
• Hosohata K, Ando H, Fujimura A. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury. J Pharmacol Exp Ther. 2012;341:656–662
   PubMed Web of Science ®Google Scholar
• Fry TJ, Mackall CL. Interleukin-7: From bench to clinic. Blood. 2002;99:3892–3904
   PubMed Web of Science ®Google Scholar